Celexa Related Published Studies
Well-designed clinical trials related to Celexa (Citalopram)
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker. [2009.09]
Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. [2009.08]
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study. [2009.07]
Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. [2009.07]
Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. [2009.07]
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. [2009.06]
Effect of a single dose of citalopram on amygdala response to emotional faces. [2009.06]
Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD). [2009.04.07]
Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: a placebo-controlled, crossover study. [2009.04]
Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. [2009.04]
Superiority of escitalopram to paroxetine in the treatment of depression. [2009.04]
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. [2009.03]
A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). [2009.03]
The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype. [2009.03]
Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study. [2009.03]
A randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). [2009.02.03]
Citalopram intervention for hostility: results of a randomized clinical trial. [2009.02]
Escitalopram: an open-label study of bereavement-related depression and grief. [2009.02]
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. [2009.01.21]
Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers. [2009]
Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: A randomized controlled trial. [2008.12.23]
No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter. [2008.12.15]
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects. [2008.12]
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. [2008.12]
[Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression] [2008.11]
Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder. [2008.11]
Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial. [2008.10.15]
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication. [2008.10.03]
Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. [2008.09]
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. [2008.08]
Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls. [2008.08]
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. [2008.07]
Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study. [2008.07]
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. [2008.07]
Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy. [2008.06]
Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. [2008.05.28]
A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. [2008.05]
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. [2008.05]
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. [2008.05]
Citalopram improves dexterity in chronic stroke patients. [2008.05]
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. [2008.04.30]
Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder. [2008.04]
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. [2008.04]
An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients. [2008.04]
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. [2008.03]
Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. [2008.03]
Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results. [2008.03]
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. [2008.03]
Escitalopram in specific phobia: results of a placebo-controlled pilot trial. [2008.03]
Escitalopram effects on insula and amygdala BOLD activation during emotional processing. [2008.03]
Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. [2008.02.15]
CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. [2008.01.12]
Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. [2008.01]
Escitalopram in the acute treatment of depressed patients aged 60 years or older. [2008.01]
Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial. [2008.01]
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. [2008.01]
Comparison of sertraline and citalopram for treatment of premature ejaculation. [2008.01]
Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data. [2008]
Bioequivalence of two commercial preparations of escitalopram oxalate/clonazepam using a liquid chromatography-electrospray mass spectrometry method. [2008]
An open-label trial of escitalopram in children and adolescents with social anxiety disorder. [2007.12]
Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. [2007.12]
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. [2007.11]
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. [2007.11]
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. [2007.10]
Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial. [2007.10]
Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. [2007.10]
Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. [2007.10]
Escitalopram in the treatment of obsessive-compulsive disorder: a double blind placebo control trial. [2007.10]
A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia. [2007.09.10]
Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. [2007.08.27]
Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report. [2007.08]
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. [2007.07]
Escitalopram prevents relapse in older patients with major depressive disorder. [2007.07]
A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. [2007.07]
Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo. [2007.07]
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. [2007.07]
An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder. [2007.07]
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. [2007.06]
Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial. [2007.05.15]
Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. [2007.05]
Pharmacokinetic comparison of two 40 mg tablet formulations of citalopram using a new amperometric detection technique. [2007.05]
Escitalopram prevents relapse of obsessive-compulsive disorder. [2007.05]
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. [2007.04]
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. [2007.04]
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. [2007.03]
Efficacy of citalopram on climacteric symptoms. [2007.03]
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. [2007.02]
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. [2007.02]
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. [2007.02]
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. [2007.01.24]
A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. [2007.01]
Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice. [2007]
The influence of educational information on depressed outpatients treated with escitalopram: A semi-naturalistic study. [2007]
Escitalopram in the treatment of anxiety symptoms associated with depression. [2007]
Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. [2007]
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. [2007]
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). [2007]
A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. [2006.12]
Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. [2006.11]
S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants. [2006.11]
Neuroendocrine effects of citalopram infusion in anorexia nervosa. [2006.11]
|
